戴维医疗
(300314)
| 流通市值：18.70亿 | | | 总市值：37.47亿 |
| 流通股本：1.44亿 | | | 总股本：2.88亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 251,904,726.04 | 112,797,919.57 | 584,030,132.77 | 392,655,821.72 |
| 营业总成本 | 234,310,985.64 | 106,008,569.07 | 506,371,105.43 | 330,449,667.87 |
| 其他经营收益 | | | | |
| 营业利润 | 26,690,797.37 | 11,582,859.93 | 98,648,091.1 | 82,770,666.46 |
| 利润总额 | 26,454,758.93 | 11,325,797.26 | 98,657,480.85 | 82,193,678.53 |
| 净利润 | 24,087,957.38 | 9,885,818.51 | 87,053,319.69 | 72,617,842.77 |
| 每股收益 | | | | |
| 其他综合收益 | -1,920,793.38 | -407,408.33 | 2,662,473.46 | 2,715,646.99 |
| 综合收益总额 | 22,167,164 | 9,478,410.18 | 89,715,793.15 | 75,333,489.76 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 919,916,631.08 | 901,669,079.49 | 934,681,736.29 | 879,256,716.39 |
| 非流动资产: | | | | |
| 非流动资产合计 | 547,585,739.27 | 548,861,873.02 | 557,086,394.21 | 564,359,409.94 |
| 资产总计 | 1,467,502,370.35 | 1,450,530,952.51 | 1,491,768,130.5 | 1,443,616,126.33 |
| 流动负债: | | | | |
| 流动负债合计 | 230,339,602.76 | 201,067,755.56 | 251,816,832.18 | 216,567,496.67 |
| 非流动负债: | | | | |
| 非流动负债合计 | 5,058,441.44 | 7,007,624.62 | 6,974,136.17 | 8,453,770.9 |
| 负债合计 | 235,398,044.2 | 208,075,380.18 | 258,790,968.35 | 225,021,267.57 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,232,104,326.15 | 1,242,455,572.33 | 1,232,977,162.15 | 1,218,594,858.76 |
| 股东权益合计 | 1,232,104,326.15 | 1,242,455,572.33 | 1,232,977,162.15 | 1,218,594,858.76 |
| 负债和股东权益合计 | 1,467,502,370.35 | 1,450,530,952.51 | 1,491,768,130.5 | 1,443,616,126.33 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 297,742,687.79 | 123,146,421.15 | 640,632,827.1 | 422,139,601.03 |
| 经营活动现金流出小计 | 294,123,931.44 | 160,605,530.26 | 551,383,091.62 | 407,335,362.63 |
| 经营活动产生的现金流量净额 | 3,618,756.35 | -37,459,109.11 | 89,249,735.48 | 14,804,238.4 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 340,478,006.03 | 196,881,085.64 | 1,191,720,777.87 | 943,424,144.47 |
| 投资活动现金流出小计 | 352,132,968.03 | 176,078,361.91 | 1,141,250,061.03 | 870,823,639.58 |
| 投资活动产生的现金流量净额 | -11,654,962 | 20,802,723.73 | 50,470,716.84 | 72,600,504.89 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 24,761,237.04 | - | 28,498,474.08 | 26,777,237.04 |
| 筹资活动产生的现金流量净额 | -24,761,237.04 | - | -28,498,474.08 | -26,777,237.04 |
| 汇率变动对现金及现金等价物的影响 | -10,900,629.87 | -4,835,763.62 | -4,870,468.09 | -1,641,416.03 |
| 现金及现金等价物净增加额 | -43,698,072.56 | -21,492,149 | 106,351,510.15 | 58,986,090.22 |
| 期末现金及现金等价物余额 | 394,214,609.74 | 416,420,533.3 | 437,912,682.3 | 390,547,262.37 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -43,698,072.56 | - | 106,351,510.15 | - |